Rick Winningham | Chairman and Chief Executive Officer |
Rhonda Farnum | Senior Vice President, Chief Business Officer |
Rick Graham | Senior Vice President, Research and Development |
Aziz Sawaf | Chief Financial Officer |
David Risinger | SVB Securities |
Douglas Tsao | H.C. Wainwright |
Eva Privitera | Cowen |
Vikram Purohit | Morgan Stanley |
Liisa Bayko | Evercore ISI |
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma Fourth Quarter and Full Year 2022 Conference Call. [Operator Instructions].
Also, today's conference is being recorded. And now I'd like to turn the call over to Rick Winningham, Chief Executive Officer.